Insmed Other Non-Current Liabilities increased by 0.7% to $5.68M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.0%, from $5.12M to $5.68M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -9.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.81M | $23.88M | $20.07M | $15.53M | $14.38M | $11.34M | $9.39M | $9.88M | $11.16M | $5.92M | $3.15M | $3.17M | $3.19M | $3.36M | $499.00K | $5.12M | $5.56M | $5.60M | $5.65M | $5.68M |
| QoQ Change | — | +86.5% | -15.9% | -22.7% | -7.4% | -21.2% | -17.2% | +5.2% | +13.0% | -47.0% | -46.9% | +0.7% | +0.9% | +5.1% | -85.1% | +926.3% | +8.6% | +0.6% | +0.9% | +0.7% |
| YoY Change | — | — | — | — | +12.3% | -52.5% | -53.2% | -36.4% | -22.4% | -47.8% | -66.5% | -67.9% | -71.4% | -43.3% | -84.1% | +61.7% | +74.2% | +66.7% | >999% | +11.0% |